• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English

Welcome to the international HTA database


Showing [16395 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for intermediate risk factors for coronary heart disease: systematic evidence synthesis
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Advagraf®) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
2009     HAYES, Inc. deCODE MI (deCODE diagnostics)
2009     HAYES, Inc. Intravascular ultrasound (IVUS) for the assessment of peripheral artery disease (PAD) of the lower extremities
2009     Agency for Healthcare Research and Quality (AHRQ) Maternal and neonatal outcomes of elective induction of labor
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for bilirubin encephalopathy
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Aripiprazole (Abilify®) tablets for the treatment of moderate to severe manic episodes in Bipolar I Disorder and for the prevention of a new manic episode in patients who experienced predominantly manic episodes and whose manic episodes responded to aripiprazole treatment
2009     University of York A systematic review of prognostic serum markers in febrile neutropenic episodes in children and young people undergoing treatment for malignant disease (Protocol for a systematic review)
2009     HAYES, Inc. Natalizumab (Tysabri, Biogen Idec and Elan Pharmaceuticals) for relapsing remitting multiple sclerosis
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in older adults: systematic review to update the 1996 U.S. Preventive Services Task Force recommendation
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Aliskiren (Rasilez®) for the treatment of essential hypertension
2009     Andalusian Health Technology Assessment Area (AETSA) [Clinical effectiveness of ozone therapies]
2009     HAYES, Inc. Percutaneous sacroplasty for treatment of sacral insufficiency fractures
2009     VA Technology Assessment Program (VATAP) Quality measures in surgery
2009     Agency for Healthcare Research and Quality (AHRQ) Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ambrisentan (Volibris®) for pulmonary arterial hypertension
2009     HAYES, Inc. Mechanical embolus removal device (Merci Retriever) (Concentric Medical Inc.) for ischemic stroke
2009     HAYES, Inc. Prehospital/emergency department therapeutic hypothermia for out-of-hospital cardiac arrest (OHCA) in adults
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for child and adolescent depression in primary care settings: a systematic evidence review for the U.S. Preventive Services Task Force
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eculizumab (Soliris®) for the treatment of paroxysmal nocturnal haemoglobinuria
2009     HAYES, Inc. Agento I.C. silver-coated endotracheal tube (C.R. Bard Inc.) for the prevention of ventilator- associated pneumonia (VAP)
2009     HAYES, Inc. Robotically assisted nephrectomy for renal malignancy using the da Vinci surgical system (Intuitive Surgical Inc.) for adult patients
2009     Agency for Healthcare Research and Quality (AHRQ) Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications. Volume 1: application of systematic review methodology to the field of nutrition
2009     Agency for Healthcare Research and Quality (AHRQ) Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Maraviroc (Celsentri®) for treatment-experienced adults infected only with CCR5-tropic HIV-1
2009     HAYES, Inc. Synvisc (hylan G-F 20) (Genzyme Corp.) for arthritis of the ankle
2009     Agency for Healthcare Research and Quality (AHRQ) Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications Volume 2: issues and challenges in conducting systematic reviews to support development of nutrient reference values: workshop summary
2009     Agency for Healthcare Research and Quality (AHRQ) Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Anidulafungin (Ecalta®) for the treatment of invasive candidiasis in adult non-neutropenic patients
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in caring type 2 diabetes mellitus patients. Literature review and economic assessment]
2009     HAYES, Inc. Allogeneic stem cell transplantation for chronic lymphocytic leukemia (CLL)
2009     HAYES, Inc. Mindstreams cognitive health assessment (NeuroTrax Corp.) product suite (U.S - Clinical Edition) for assessing mild cognitive impairment
2009     HAYES, Inc. Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2009     Agency for Healthcare Research and Quality (AHRQ) Nutritional research series: advancing the role of evidence-based reviews in nutrition research and applications. Volume 3: reporting of systematic reviews of micronutrients and health: a critical appraisal
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Nelarabine (Atriance®) for the treatment of T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma
2009     HAYES, Inc. Acupuncture for treatment of headache
2009     Agency for Healthcare Research and Quality (AHRQ) Evaluating test strategies for colorectal cancer screening - age to begin, age to stop, and timing of screening intervals: a decision analysis of colorectal cancer screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET).
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Thalidomide (Thalidomide Pharmion®) in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged GE 65 years or ineligible for high dose chemotherapy
2009     Andalusian Health Technology Assessment Area (AETSA) [Organisational models in palliative care. A comparison on consumption of resources]
2009     HAYES, Inc. Acupuncture for treatment of postoperative pain
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Efavirenz / emtricitabine / tenofovir disoproxil (as fumarate) (Atripla®) for the treatment of HIV-1 infection in adults
2009     HAYES, Inc. Antimicrobial central venous catheters
2009     HAYES, Inc. Combined positron emission tomography-computed tomography (PET-CT) for lung
2009     HAYES, Inc. Antibacterial suture for prevention of infection
2009     HAYES, Inc. Computer-assisted cognitive-behavioral treatment for depression
2009     HAYES, Inc. D-Cycloserine for anxiety disorders
2009     HAYES, Inc. Direct brain tissue oxygen monitoring for traumatic brain injury
2009     HAYES, Inc. Myotonic dystrophy types 1 and 2
2009     HAYES, Inc. Endovascular repair of abdominal Aortic aneurysms
2009     HAYES, Inc. Epsilon-aminocaproic acid and tranexamic acid for coronary artery bypass graft surgery
2009     HAYES, Inc. Nebulized antibiotic therapy for chronic sinusitis
2009     HAYES, Inc. Etanercept for ankylosing spondylitis
2009     VA Technology Assessment Program (VATAP) Visual problems in traumatic brain injury
2009     HAYES, Inc. NK pressure-specified sensory device (Sensory Management Services LLC) for tarsal tunnel syndrome diagnosis
2009     HAYES, Inc. Etanercept for psoriasis and psoriatic arthritis
2009     Belgian Health Care Knowledge Centre (KCE) Magnetic Resonance Imaging: cost analysis
2009     VA Technology Assessment Program (VATAP) Complementary and alternative therapies for post-traumatic stress disorder
2009     HAYES, Inc. High-intensity focused ultrasound treatment for prostate cancer
2009     HAYES, Inc. Beds and mattresses designed to prevent pressure ulcers
2009     HAYES, Inc. NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for treatment of acute intracerebral hemorrhage
2009     HAYES, Inc. Spinal muscular atrophy
2009     HAYES, Inc. Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from cancers of the lower gastrointestinal tract
2009     HAYES, Inc. NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for treatment of surgical bleeding
2009     HAYES, Inc. Spinocerebellar Ataxia Type 1
2009     HAYES, Inc. Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from gastric cancer
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Comparative analysis of bedpan processing equipment
2009     HAYES, Inc. Biofeedback for the treatment of dysfunctional voiding in children
2009     HAYES, Inc. Spinocerebellar Ataxia Type 2
2009     HAYES, Inc. Intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis resulting from ovarian cancer, peritoneal mesothelioma, or abdominal sarcoma
2009     HAYES, Inc. Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
2009     HAYES, Inc. Lumbar total disc replacement for degenerative disc disease
2009     HAYES, Inc. Spinocerebellar Ataxia Type 6
2009     HAYES, Inc. Multichannel intraluminal impedance testing for gastroesophageal reflux disease (GERD)
2009     HAYES, Inc. Nonpharmacological Treatments for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children:Behavior Therapy
2009     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation
2009     HAYES, Inc. Stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD) in children
2009     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of lipid-modifying agents
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Clinical practice guideline on schizophrenia and early psychotic disorders
2009     Adelaide Health Technology Assessment (AHTA) Molecular testing for myeloproliferative disease
2009     HAYES, Inc. Sublingual immunotherapy for allergic rhinitis and asthma
2009     Adelaide Health Technology Assessment (AHTA) Cryotherapy for recurrent prostate cancer and renal cancer
2009     HAYES, Inc. Transanal endoscopic microsurgery for rectal carcinoma
2009     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of angiotensin converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease
2009     HAYES, Inc. Percutaneous mechanical thrombectomy for acute limb ischemia with the AngioJet rheolytic thrombectomy system (Possis Medical Inc.)
2009     HAYES, Inc. CYP2C19 Genotyping to determine response to clopidogrel
2009     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of medications to reduce risk of primary breast cancer in women
2009     HAYES, Inc. FMR1 testing for Fragile X-Associated Tremor/Ataxia Syndrome
2009     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of core-needle and open surgical biopsy for the diagnosis of breast lesions
2009     Adelaide Health Technology Assessment (AHTA) The management of acute/subacute soft tissue injuries to the low back: Evidence update and recommendations for clinical practice
2009     HAYES, Inc. Genetic testing for long QT syndrome using the Familion Test (PGxHealth)
2009     HAYES, Inc. Invitrogen SPOT-Light HER2 CISH Kit
2009     Health Information and Quality Authority (HIQA) Report of the evaluation of the use of resources in the national population-based cancer screening programmes and associated services
2009     HAYES, Inc. Spinocerebellar Ataxia Type 10 (SCA10)
2009     HAYES, Inc. Spinocerebellar Ataxia Type 12 (SCA12)
2009     HAYES, Inc. ChemoFX assay (Precision Therapeutics Inc.) for prediction of response to chemotherapy
2009     HAYES, Inc. Spinocerebellar Ataxia Type 17 (SCA17)
2009     HAYES, Inc. ChloraPrep for skin antisepsis
2009     HAYES, Inc. Spinocerebellar Ataxia Type 7
2009     HAYES, Inc. Coil embolization for pelvic congestion syndrome (PCS)
2009     HAYES, Inc. Spinocerebellar Ataxia Type 8 (SCA8)